# Meropenem

NDC: 63323-507
Generic name: Meropenem
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20111014

FDA application: ANDA091404

## Active ingredients

- MEROPENEM: 500 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-507"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-507
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12714f80-d6e5-4453-b66c-62f57c16ddfc